Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a neuropsychiatric disorder. Emerging evidence suggests that gut microbiota may contribute to ADHD pathogenesis and that microbiota modulation could improve its symptoms. This study evaluated the safety and efficacy of a probiotic mixture containing Bifidobacterium animalis subsp. lactis BLa80 and Lacticaseibacillus rhamnosus LRa05 in children with ADHD. An open-label, single-arm trial enrolled children with ADHD (n = 42) who received daily oral probiotics (5 × 10 CFU) for 8 weeks. BRIEF-II and SNAP-IV scales were administered at baseline, Week 5, and Week 9 to assess changes in symptoms. Probiotic intervention significantly reduced scores in BRIEF-II domains (Global Executive Composite, Behavior Regulation Index, Emotion Regulation Index, and Cognitive Regulation Index) and SNAP-IV subscales (Inattention, Hyperactivity-Impulsivity) at Week 9 (all p < 0.05). One participant experienced mild diarrhea (grade 1, resolved spontaneously). No significant changes in hematological/biochemical parameters were observed. This exploratory study found that the probiotic mixture is safe and may improve ADHD symptoms in children, warranting further controlled trials to validate its efficacy and explore the underlying mechanisms. This study has been registered in a clinical trial registry. Trial Registration: ClinicalTrials.gov identifier: NCT06348121.

Download full-text PDF

Source
http://dx.doi.org/10.1002/mnfr.70234DOI Listing

Publication Analysis

Top Keywords

probiotic mixture
12
mixture bifidobacterium
8
bifidobacterium animalis
8
animalis subsp
8
subsp lactis
8
lactis bla80
8
bla80 lacticaseibacillus
8
lacticaseibacillus rhamnosus
8
rhamnosus lra05
8
lra05 children
8

Similar Publications

Mild cognitive impairment progresses slowly and may be reversible, providing a window of opportunity for intervention before it progresses to Alzheimer's disease, at which point treatments, at best, ameliorate symptoms with little efficacy towards delaying disease progression. The gut and brain communicate through the gut-brain axis, and derangement of the gut microbiome has been shown to promote neuroinflammation, a process intricately linked to pathological progression to mild cognitive impairment and subsequent neurocognitive diseases. In preclinical trials, probiotics modulated the gut microbiome in a way that was neuroprotective.

View Article and Find Full Text PDF

The aim of the presented study was to investigate the effects of prebiotic inulin, probiotic VSL#3 (mixture of bacteria from 7 different species and 8 strains) and synbiotic (inulin + VSL#3) supplements applied together with lacosamide (LCM) on post-traumatic epilepsy (PTE). In addition, effectiveness of the relevant treatments on comorbid problems related to learning and memory, anxiety, motor performance and pain threshold that may develop together with seizures due to traumatic brain injury (TBI) and PTE was also examined using behavioral tests. In experiments, adult male Sprague-Dawley rats, divided into 6 groups, were given 30 mg/kg LCM or 1000 mg/kg inulin together with LCM as prebiotic, VSL#3 mixture containing 10 × 10 CFU/kg bacterial colonies as probiotic and (inulin + VSL#3) as synbiotic for 28 days by oral gavage after mild-TBI was induced by weight-drop method and electroencephalogram electrodes were placed.

View Article and Find Full Text PDF

Coccidiosis is an enteric protozoan parasitic disease that results in significant economic losses due to high mortality and morbidity, particularly in poultry farms run on a deep litter system, as well as the costs associated with its treatment and control. From time to time, several approaches have been adopted for its prevention and control, among which current approaches include the use of anticoccidial drugs, herbal plants, and vaccines. Anticoccidial drugs work well to stop coccidiosis, but their use is limited because some strains are becoming partially or completely resistant to them.

View Article and Find Full Text PDF

Nonalcoholic fatty liver disease (NAFLD) is a global health issue, often associated with gut dysbiosis. In recent years, probiotics have gained attention as potential therapeutic agents for NAFLD. This study explored the effects of a single strain, with high surfactin secretion, on C57BL/6 mice fed a high-fat diet (HFD), a model for NAFLD, for 13 weeks.

View Article and Find Full Text PDF

Attention-deficit/hyperactivity disorder (ADHD) is a neuropsychiatric disorder. Emerging evidence suggests that gut microbiota may contribute to ADHD pathogenesis and that microbiota modulation could improve its symptoms. This study evaluated the safety and efficacy of a probiotic mixture containing Bifidobacterium animalis subsp.

View Article and Find Full Text PDF